These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35092502)

  • 21. Expression analysis of selected miR-206 targets from the transforming growth factor-β signaling pathway in breast cancer.
    Seifi-Alan M; Dianatpour A; Geranpayeh L; Mirfakhraie R; Omrani MD; Ghafouri-Fard S
    J Cell Biochem; 2019 Aug; 120(8):13545-13553. PubMed ID: 30920079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cisatracurium regulates the CXCR4/let-7a-5p axis to inhibit colorectal cancer progression by suppressing TGF-β/SMAD2/3 signalling.
    Xia YZ; Shan GF; Yang H; Zha J; Wang L; Chen JM; Zhang XS
    Chem Biol Interact; 2021 Apr; 339():109424. PubMed ID: 33617803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct roles and differential expression levels of Wnt5a mRNA isoforms in colorectal cancer cells.
    Huang TC; Lee PT; Wu MH; Huang CC; Ko CY; Lee YC; Lin DY; Cheng YW; Lee KH
    PLoS One; 2017; 12(8):e0181034. PubMed ID: 28859077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of Lgr5, a marker of intestinal stem cells, in colorectal cancer and its clinicopathological significance.
    He S; Zhou H; Zhu X; Hu S; Fei M; Wan D; Gu W; Yang X; Shi D; Zhou J; Zhou J; Zhu Z; Wang L; Li D; Zhang Y
    Biomed Pharmacother; 2014 Jun; 68(5):507-13. PubMed ID: 24751002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hsa_circ_0005075 predicts a poor prognosis and acts as an oncogene in colorectal cancer via activating Wnt/β-catenin pathway.
    Jin YD; Ren YR; Gao YX; Zhang L; Ding Z
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3311-3319. PubMed ID: 31081084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A low-frequency variant in SMAD7 modulates TGF-β signaling and confers risk for colorectal cancer in Chinese population.
    Li J; Zou L; Zhou Y; Li L; Zhu Y; Yang Y; Gong Y; Lou J; Ke J; Zhang Y; Tian J; Zou D; Peng X; Chang J; Gong J; Zhong R; Zhou X; Miao X
    Mol Carcinog; 2017 Jul; 56(7):1798-1807. PubMed ID: 28218435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NUP153 overexpression suppresses the proliferation of colorectal cancer by negatively regulating Wnt/β-catenin signaling pathway and predicts good prognosis.
    Wu Y; Fang G; Wang X; Wang H; Chen W; Li L; Ye T; Gong L; Ke C; Cai Y
    Cancer Biomark; 2019; 24(1):61-70. PubMed ID: 30347601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alterations in the EGFR pathway coincide in colorectal cancer and impact on prognosis.
    Neumann J; Wehweck L; Maatz S; Engel J; Kirchner T; Jung A
    Virchows Arch; 2013 Oct; 463(4):509-23. PubMed ID: 23934607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer.
    Zhang Y; Guo L; Li Y; Feng GH; Teng F; Li W; Zhou Q
    Mol Cancer; 2018 Jan; 17(1):1. PubMed ID: 29304823
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Cheng C; Huang Z; Zhou R; An H; Cao G; Ye J; Huang C; Wu D
    Am J Physiol Gastrointest Liver Physiol; 2020 May; 318(5):G841-G853. PubMed ID: 32146835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1.
    Wang X; Lai Q; He J; Li Q; Ding J; Lan Z; Gu C; Yan Q; Fang Y; Zhao X; Liu S
    Int J Med Sci; 2019; 16(1):51-59. PubMed ID: 30662328
    [No Abstract]   [Full Text] [Related]  

  • 33. Transposon mutagenesis identifies candidate genes that cooperate with loss of transforming growth factor-beta signaling in mouse intestinal neoplasms.
    Morris SM; Davison J; Carter KT; O'Leary RM; Trobridge P; Knoblaugh SE; Myeroff LL; Markowitz SD; Brett BT; Scheetz TE; Dupuy AJ; Starr TK; Grady WM
    Int J Cancer; 2017 Feb; 140(4):853-863. PubMed ID: 27790711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of tumor progression-related gene expression in colorectal cancer patients.
    Uhlmann ME; Georgieva M; Sill M; Linnemann U; Berger MR
    J Cancer Res Clin Oncol; 2012 Oct; 138(10):1631-40. PubMed ID: 22614156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer.
    Lemieux E; Cagnol S; Beaudry K; Carrier J; Rivard N
    Oncogene; 2015 Sep; 34(38):4914-27. PubMed ID: 25500543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long noncoding RNA LINC00978 acts as a potential diagnostic biomarker in patients with colorectal cancer.
    Ghasemian M; Rajabibazl M; Mirfakhraie R; Razavi AE; Sadeghi H
    Exp Mol Pathol; 2021 Oct; 122():104666. PubMed ID: 34273360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SMAD2, SMAD3 and SMAD4 mutations in colorectal cancer.
    Fleming NI; Jorissen RN; Mouradov D; Christie M; Sakthianandeswaren A; Palmieri M; Day F; Li S; Tsui C; Lipton L; Desai J; Jones IT; McLaughlin S; Ward RL; Hawkins NJ; Ruszkiewicz AR; Moore J; Zhu HJ; Mariadason JM; Burgess AW; Busam D; Zhao Q; Strausberg RL; Gibbs P; Sieber OM
    Cancer Res; 2013 Jan; 73(2):725-35. PubMed ID: 23139211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. WNT4 secreted by tumor tissues promotes tumor progression in colorectal cancer by activation of the Wnt/β-catenin signalling pathway.
    Yang D; Li Q; Shang R; Yao L; Wu L; Zhang M; Zhang L; Xu M; Lu Z; Zhou J; Huang L; Huang X; Cheng D; Yang Y; Yu H
    J Exp Clin Cancer Res; 2020 Nov; 39(1):251. PubMed ID: 33222684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transforming Growth Factor-β Signaling Pathway in Colorectal Cancer and Its Tumor Microenvironment.
    Itatani Y; Kawada K; Sakai Y
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31756952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimetastatic role of Smad4 signaling in colorectal cancer.
    Zhang B; Halder SK; Kashikar ND; Cho YJ; Datta A; Gorden DL; Datta PK
    Gastroenterology; 2010 Mar; 138(3):969-80.e1-3. PubMed ID: 19909744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.